Prevalence of rare cancer survivors in the United States

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This observational analysis estimates rare cancer prevalence in the US, showing about 5 million survivors, with many being long-term survivors.

Nearly 5 million individuals in the US have survived a rare cancer diagnosis, indicating a significant survivor population overall.
The study reveals 69.9% of these survivors are long-term, existing over five years post-diagnosis, emphasizing extended cancer survivorship.
Using joinpoint regression models, the research assessed trends in incidence and mortality across different rare cancer types.
The high prevalence of survivors highlights the need for focused survivorship care tailored to rare cancer patients.

Gallicchio et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This observational analysis estimates rare cancer prevalence in the US, showing about 5 million survivors, with many being long-term survivors.